Market Mondays: Trump’s Prescription Drug Order, Amazon’s AMD Power Play & Future of Healthcare Stocks

Released on May 17, 2025, "Market Mondays" hosted by the EYL Network delves into the latest developments in the stock market and investment strategies. In this episode, Ian Dunlap and co-hosts discuss the ramifications of President Trump's executive order on prescription drug prices, Amazon's strategic investment in AMD, and the broader implications for healthcare and technology stocks.

1. Trump’s Executive Order on Prescription Drug Prices

Overview of the Order

The episode kicks off with a discussion on President Trump's newly signed executive order aimed at reducing prescription drug prices across the United States. While the order hasn't yet impacted healthcare stocks immediately, its long-term effects are a primary concern for investors.

Impact on Healthcare Stocks

Ian Dunlap examines the potential consequences of the order on various pharmaceutical companies. He notes, “If executed correctly, then this could be helpful to a lot of people that have prescription drugs that they're taking, but it's not helpful to the companies that actually provide these drugs” (02:00). Dunlap anticipates that companies relying on legacy drugs and lacking innovation, such as Pfizer, may face significant challenges. Conversely, companies like Lilly and Novo Nordisk might weather the storm more effectively.

Economic and Market Implications

Dunlap emphasizes the need for fair pricing in the pharmaceutical industry. “Why is the same drug in another country 80% cheaper? I can't argue with that now” (02:40). This discrepancy highlights the necessity for the executive order, despite its potentially adverse effects on certain companies. The hosts discuss how this move could stimulate innovation within the industry, pushing companies to develop new and affordable drugs.

Political and Legal Considerations

The order's passage is not without hurdles. Dunlap points out, “There’ll be plenty of pressure from lobbying” (03:37), indicating that pharmaceutical lobbyists will likely challenge the order in courts. This legal battle adds uncertainty to the market's reaction. The immediate market response saw a slight dip in healthcare stocks following the announcement, reflecting investor concerns about the order’s execution and potential litigation.

Host Perspectives

Co-hosts express a balanced view on the executive order. They acknowledge the benefits to consumers but remain wary of the order's implementation and its long-term impact on the healthcare sector. “Makes a lot of sense when you look at how much drugs cost here” (05:12) underscores their support for the initiative despite the challenges it poses to pharmaceutical companies.

2. Amazon’s Strategic Investment in AMD

Details of the Investment

The conversation shifts to Amazon's strategic maneuver involving Advanced Micro Devices (AMD). Initially, it was unclear whether Amazon intended to acquire AMD directly. However, the reality unfolded when Amazon’s acquisition of ZT Group International, a server manufacturer, resulted in Amazon receiving over 820,000 AMD shares as part of a stock buyout. “Technically, they didn't buy it. But because they had ownership in the company they got” (06:05), Dunlap explains the nuances of the investment.

Strategic Implications for Amazon and AMD

This move signifies Amazon’s intent to bolster its AI infrastructure. “When you look at how much drugs cost here, it's opposed to other places when it's being manufactured here. Doesn’t make sense” (05:17) and “We don’t have to rely on outside people anymore” (06:40) highlight Amazon’s strategy to internalize critical technology assets. By securing a stake in AMD, Amazon ensures a steady supply of high-performance chips essential for AI and machine learning applications, reducing dependency on external suppliers.

Market and Technological Impact

The investment is seen as a positive signal for AMD. “They still have the equity in the asset though, which I'm not mad at. Amazon has been on the terror” (07:30) suggests confidence in AMD’s future prospects, particularly in the GPU space vital for AI advancements. This partnership is expected to enhance AMD’s market position, especially as AI demand continues to surge. “And then I think eventually AMD will make a push up to the upside” (07:30) indicates potential stock appreciation driven by increased demand for AMD’s technology.

Comparisons and Industry Trends

The hosts draw parallels to other tech giants’ strategies, such as Apple’s move away from Intel to develop in-house chips. “Apple said, hey, we’re not gonna use Intel anymore. We’ll make our own chip” (08:07), Dunlap compares this trend to Amazon’s investment in AMD, emphasizing a broader industry shift towards self-reliance in critical technology components.

Future Projections

With Amazon committing substantial resources to AI, the partnership with AMD is poised to drive significant advancements. “Amazon said they're spending a hundred billion on AI infrastructure” (08:07) underscores the magnitude of Amazon’s investment in AI, with AMD playing a crucial role in powering these innovations. The hosts anticipate that this collaboration will not only benefit AMD through increased sales and technological advancements but also fortify Amazon’s position in the AI and cloud computing markets.

3. Additional Topics

Florida’s Property Tax Proposal

Briefly touched upon is the proposal to eliminate property taxes in Florida, championed by figures like Ron DeSantis and echoed by Donald Trump. While viewed as an appealing idea due to its potential benefits to property owners, the hosts are skeptical about its feasibility. “I don't think it's gonna happen” (04:28) reflects their doubts about the proposal's likelihood of passing through legislative hurdles.

Foreign Policy Remarks

Towards the end of the discussion, there’s a nod to Trump’s foreign policy, which the hosts plan to elaborate on in future episodes. “He’s doing some things that I think are beneficial for sure. His foreign policy. We'll talk about that on Wednesday” (04:52) indicates upcoming topics related to international relations and their impact on the market.

Conclusion

In this episode of "Market Mondays," Ian Dunlap and co-hosts provide insightful analysis on two major developments: President Trump's executive order on prescription drug prices and Amazon's strategic investment in AMD. They explore the immediate and long-term implications for the healthcare and technology sectors, offering a nuanced perspective that balances potential benefits with foreseeable challenges. The discussion underscores the interconnectedness of policy decisions and corporate strategies in shaping market dynamics, providing listeners with valuable takeaways for informed investment decisions.

For listeners seeking to stay abreast of market trends and investment strategies, this episode offers a comprehensive examination of pivotal events influencing the financial landscape.